Argatroban is a direct thrombin inhibitor that can be used to anticoagulate a patient with heparin-induced thrombocytopenia (HIT).
Administration: infusion
Patient Condition |
Initial Dose Rate |
normal hepatic and renal function |
2 micrograms per kg |
estimated creatinine clearance < 60 mL per minute |
1 microgram per kg |
hepatic insufficiency |
0.5 micrograms per kg |
initial infusion in micrograms per minute =
= (dose rate) * (dosing weight in kilograms)
For a morbidly obese patient the dosing weight may be less than the actual body weight.
The infusion is adjusted to maintain a target aPTT.
Patient Condition |
Target Range aPTT |
not high risk for bleeding |
2 to 2.5 times reference |
high for bleeding |
1.5 to 2 times reference |
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical, Critical Care, Immunology/Rheumatology